Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Critical Care Nurses Do Not Have Access to Tools They Need to Treat Sepsis

December 21, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

DURHAM, N.C., Dec. 21, 2010 /- bioMerieux, a world leader in the field of in vitro diagnostics, announced the results of a survey demonstrating that most critical care nurses are unaware of a simple diagnostic test that may dramatically improve outcomes for sepsis patients. The survey,...

TOPICS:

Generational Equity Announces Sale of B-Pharm, Inc. dba Remedies Pharmacy to a Private Investment Group

December 21, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, Dec. 21, 2010 /- Generational Equity, a leading advisor to privately held and family-owned businesses for mergers, acquisitions, strategic growth initiatives, business valuation and exit planning announced the acquisition of its client, B-Pharm, Inc. dba Remedies Pharmacy,...

TOPICS:

Cambridge Heart takes in $2.9M

December 21, 2010 6:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge Heart Inc., the Tewksbury-based developer of diagnostic heart tests for cardiac disease, has raised $2.9 million in a private placement, the company reported today.

Advertisement

PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis

December 21, 2010 5:30 am | by Bio-Medicine.Org | News | Comments

SOUTH PLAINFIELD, N.J., Dec. 21, 2010 /- PTC Therapeutics, Inc. announced today that it has completed enrollment of a Phase 3 clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation cystic fibrosis (nmCF). (Logo:...

TOPICS:

Federal Register: Meetings: Advisory Committees; Tentative Schedule for 2011

December 21, 2010 4:34 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2011.

Biogen buys Neurimmune unit for up to $427M

December 21, 2010 4:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Biogen Idec Inc. has bought a subsidiary of Swiss firm Neurimmune Holding AG in a move that will give Biogen potential treatments for neurodegenerative disease like Parkinson's disease, at a total potential cost of $427 million.

Genzyme touts market potential for MS drug

December 21, 2010 4:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Genzyme Corp. appeared to go on the offensive Monday in making its point that the Cambridge biotech is worth more than the $69 per share price offered by Sanofi-aventis in its takeover bid.

Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.

December 21, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 21, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced that it has completed the acquisition of Beijing Montagne Medical Device Co., Ltd.  The acquisition further enhances Zimmer's presence in the emerging Chinese...

TOPICS:
Advertisement

INVO Bioscience Announces First Shipments of INVOcell Into Bolivia

December 21, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BEVERLY, Mass., Dec. 21, 2010 /- INVO Bioscience, Inc. (OTC Bulletin Board: IVOB ), a medical device company focused on treatment options for patients diagnosed with infertility, today announced the initial shipments of the INVOcell device into Bolivia.  The initial order of INVOcell...

TOPICS:

Microscopes fit within a miniaturized chip

December 21, 2010 3:37 am | by I-Micronews | News | Comments

Using a plate of silicon containing dozens of miniature lenses, scientists at Harvard University, United States, say they are very close to putting large capacity of microscopes used in their laboratories inside a device no bigger than a chip computer.

ERT Announces the Appointment of Joel Morganroth, MD as Interim CEO

December 21, 2010 3:33 am | by RealWire | News | Comments

PHILADELPHIA, PA, 21 December 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, today confirmed that the effective date of the previously announced retirement of Dr. Michael J. McKelvey, its President and CEO, is...

TOPICS:

Advanced Laser Therapy Solutions for Women's Hair Loss

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Many Women suffering from hair loss are turning to Advanced Hair Studio s and discovering advanced laser therapy as a method along with other procedures to overcome thinning hair. This method of hair restoration has been shown to be affective in helping a woman's...

TOPICS:

Silence Therapeutics Provides Year-end Update

December 20, 2010 10:31 pm | by Bio-Medicine.Org | News | Comments

LONDON, Dec. 21, 2010 /- Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), a leading global biotechnology company dedicated to the discovery, development and delivery of targeted, systemic RNA interference (RNAi) therapeutics for the treatment of serious diseases, today...

TOPICS:

DSM to buy US biotech company Martek for $1.09B

December 20, 2010 9:45 pm | by The Associated Press | News | Comments

Royal DSM NV, the Dutch chemicals company, says it plans to buy US biotech firm Martek Biosciences Corp for $1.09 billion (€83 million) in cash, in a management supported deal.The Dutch company says its $31.50 per share offer for Martek represents a 35 percent premium to Martek's closing price...

Quitting menthol cigarettes may be harder for some smokers

December 20, 2010 8:35 pm | by EurekAlert | News | Comments

(Penn State) Menthol cigarettes may be harder to quit, particularly for some teens and African-Americans, who have the highest menthol cigarette use, according to a study by a team of researchers.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading